Open Access

Conservative Treatment for Congenital Nasolacrimal Duct Obstruction – Factors Affecting the Success


Cite

1. Guerry D, Kendig EL. Congenital impatency on the naso-lacrimal duct. Arch Ophthalmol, 1948, 39, 193-204.10.1001/archopht.1948.00900020198006Search in Google Scholar

2. Khan N, Khan MN, Jan S, Mohammad S. Congenital Nasolacrimal Duct Obstruction: Presentation and Mangement. Pak J Ophthalmol, 2006, 22 (2), 74-78.Search in Google Scholar

3. Zappia RJ, Milder B. Lacrimal drainage function: the fluorescein dye disappearance test. Am J Ophthalmol, 1972, 74, 160-162.10.1016/0002-9394(72)91142-7Search in Google Scholar

4. MacEwen CJ, Young JDH. Epiphora During the First Year of Life. Eye (Lond), 1991, 5 (5), 596-600.10.1038/eye.1991.103Search in Google Scholar

5. Ghuman T, Gonzales C, Mazon ML. Treatment of congenital nasolacrimal duct obstruction. Am J Orthopt, 1999, 49, 161-166.10.1080/0065955X.1999.11982207Search in Google Scholar

6. Pediatric Eye Disease Investigator Group (PEDIG). Resolution of Congenital Nasolacrimal Duct Obstruction with Nonsurgical Management. Arch Ophthalmol, 2012, 130(6), 730-734.10.1001/archophthalmol.2012.454Search in Google Scholar

7. Crigler LW. The treatment of congenital dacryocystitis. JAMA, 1923, 81, 23-24.10.1001/jama.1923.02650010027009Search in Google Scholar

8. Nelson LB, Calhoun JH, Menduke H. Medical Management of Congenital Nasolacrimal Duct Obstruction. Ophthalmology, 1985, 92, 1187-1190.10.1016/S0161-6420(85)33878-2Search in Google Scholar

9. Takahashi Y, Kakizaki H, Chan WO, Selva D. Management of congenital nasolacrimal duct obstruction. Acta Ophthalmol, 2010, 88(5), 506-513.10.1111/j.1755-3768.2009.01592.x19681790Search in Google Scholar

10. MacEwen CJ, Young JDH. The fluorescein disappearance test: an evaluation of its use in infants. J Pediatr Ophthalmol Strab, 1991, 28, 302-305.10.3928/0191-3913-19911101-041757852Search in Google Scholar

11. Dareshani S, Saleem T, Quraishy MM. Crigler Massage In Congenital Nasolacrimal Duct Obstruction. Medical Chanel, 2013, 19 (4), 21-23.Search in Google Scholar

12. Kakizaki H, Takahashi Y, Kinoshita S, et al. The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age. Clinical Ophthalmology, 2008, 2(2), 291-294.10.2147/OPTH.S2582269398119668718Search in Google Scholar

13. Katowitz JA, Welsh MG. Timing of initial probing and irrigation in congenital buct obstruction. Ophthalmology, 1987, 94, 698-705.10.1016/S0161-6420(87)33392-5Search in Google Scholar

14. Young JDH, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: A multicentre trial of management. Eye, 1996, 10, 485-491.10.1038/eye.1996.1078944104Search in Google Scholar

eISSN:
2719-5384
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Basic Medical Science, Immunology, Clinical Medicine, other